Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Anemia and thrombocytosis induced by ribavirin monotherapy in patients with chronic hepatitis C

Published:2012-03-30 Issue:11 Volume:47 Page:1228-1237
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kobayashi Tomoe,Hige Shuhei,Terashita Katsumi,Nakai Masato,Horimoto Hiromasa,Sho Takuya,Nakanishi Mitsuru,Ogawa Koji,Chuma Makoto,Sakamoto Naoya,Asaka Masahiro

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00535-012-0579-y.pdf

Reference26 articles.

1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107–15.

2. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284:450–6.

3. di Iulio J, Ciuffi A, Fitzmaurice K, Kelleher D, Rotger M, Fellay J, et al. Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology. 2011;53:1446–54.

4. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975–82.

5. Hadziyannis SJ, Sette H, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med. 2004;140:346–55.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hemolytic Anemia and Reactive Thrombocytosis Associated With Cefoperazone/Sulbactam;Frontiers in Pharmacology;2019-11-08

2. A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms;Journal of Clinical Laboratory Analysis;2018-04-16

3. Retinal vascular complications associated with interferon-ribavirin therapy for chronic hepatitis C: A population-based study;Pharmacoepidemiology and Drug Safety;2017-12-06

4. Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis;European Journal of Gastroenterology & Hepatology;2017-10

5. A Look at Platelet Count in Chronic Hepatitis C Infection;EMJ Hepatology;2017